Statkov P R
Fortschr Med. 1978 May 18;96(19):1046-8.
According to the results obtained under the described conditions it can be stated that after i.v. administration Adyston induces a dose-dependent rise in systolic and diastolic blood pressure, in comparison with etilefrin the new product Adyston shows a greater potency in rising the systolic and diastolic blood pressure; Adyston induced rise of blood pressure is in general of longer duration in comparison with that induced by etilefrin, it is interesting that in the dose of 0.01 mg/kg Adyston increases the arterial blood pressure but at the same time slightly decreases the heart rate; this is not the case after administration of etilefrin which at the same dose increases both arterial blood pressure and heart rate.
根据在所述条件下获得的结果,可以得出以下结论:静脉注射后,阿地斯顿会引起收缩压和舒张压呈剂量依赖性升高,与依托福林相比,新产品阿地斯顿在升高收缩压和舒张压方面表现出更大的效力;与依托福林引起的血压升高相比,阿地斯顿引起的血压升高通常持续时间更长,有趣的是,在0.01mg/kg的剂量下,阿地斯顿会升高动脉血压,但同时会略微降低心率;而注射依托福林后情况并非如此,在相同剂量下,依托福林会同时升高动脉血压和心率。